Orelox Suspension 100ml (Cefpodoxime Proxetil)
₦16,000.00
Orelox Suspension is an antibiotic formulation containing cefpodoxime proxetil, a broad-spectrum cephalosporin antibiotic. It is designed for oral administration, making it suitable for children and adults in treating various bacterial infections.
Key Features:
- Active Ingredient:
- Cefpodoxime Proxetil: A prodrug that converts to cefpodoxime in the body, effectively inhibiting bacterial cell wall synthesis and leading to the death of susceptible bacteria.
- Indications:
- Used to treat a range of infections, including:
- Respiratory tract infections (e.g., pneumonia, bronchitis)
- Ear infections (otitis media)
- Skin and soft tissue infections
- Urinary tract infections
- Pharyngitis and tonsillitis
- Used to treat a range of infections, including:
- Dosage Form:
- Available as a suspension for convenient dosing, especially in pediatric patients.
Usage:
- Dosage:
- The dosage should be determined by a healthcare provider based on the patient’s age, weight, and severity of the infection. Typical dosages may vary.
- Administration:
- Shake the bottle well before use. Measure the dose carefully using the provided measuring device. It can be taken with or without food.
Precautions:
- Allergies:
- Inform your healthcare provider of any known allergies to cephalosporins or penicillins.
- Side Effects:
- Possible side effects may include gastrointestinal disturbances (nausea, vomiting, diarrhea), allergic reactions, and skin rashes. Report any severe or persistent side effects immediately.
- Interactions:
- Discuss any other medications you are taking to avoid potential interactions, particularly with anticoagulants and other antibiotics.
Storage:
- Store in a cool, dry place, and refrigerate after reconstitution if necessary. Keep out of reach of children.
- Very secured payment methods
- Shipping will be calculated on checkout
- Please note that price may increase due to exchange rate, ensure updated price before making payment
Dispensing supervised byPharm. Tope Kareem, B.PharmPCN Reg. 023669
Last updated 28 August 2026How we write and check this informationPCN Premises Licence LAG20247B39C9




